milvexian,milvexian section
bms,janssen
['factor xi', 'axiomatic-ssp', 'milvexian']
late-breaking results from phase 2 axiomatic-ssp study of milvexian, an investigational oral factor xia inhibitor, show favorable antithrombotic profile in combination with dual antiplatelet therapy 
News forum for top stories in Cardiac and Vascular to include cardiovascular, structural heart, PV, EVAR, TAVR, Interventional, neurovascular @PrimeCoreSearch